We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Sentinel Diagnostics

Sentinel Diagnostics develops and manufactures in-vitro diagnostic medical devices for routine analysis and specific ... read more Featured Products: More products

Download Mobile App





Sentinel Diagnostics Presents Latest Breakthroughs in Diagnostics

By LabMedica International staff writers
Posted on 12 Nov 2024

Sentinel Diagnostics (Milano, Italy) is sharing its latest breakthroughs in medical diagnostics at MEDICA 2024. More...

The company is also hosting exciting presentations on molecular diagnostics, fecal immunochemical testing (FIT), chromatography, and lateral flow tests.

At this year’s MEDICA, Sentinel is showcasing is wide portfolio of compatible freeze-dried kits based on its proprietary STAT-NAT (Stabilized Amplification Technology) technology that has been developed with a new protective compound able to stabilize the activity of enzymes for a very long time with no temperature-controlled storage requirements. STAT-NAT technology yields very good performances in all the most diffused molecular biology techniques. It can improve test sensitivity even with low-concentrated DNA samples and contains all the reaction components. Sentinel is also highlighting its lyophilized STAT-NAT kits for various application areas such as virology, healthcare-associated infections, parasitology, and respiratory infections.

Designed to work with the lyophilized kits is Sentinel’s SENTiNAT 200 molecular diagnostics system that contains everything needed to perform a complete PCR analysis- rom sample extraction to Real-Time PCR results interpretation. The fully automated multiparametric system for pathogens detection can perform a multiparametric analysis on different matrices from one or more patients, using the same extraction and amplification protocol. Smart software takes care of every step of the process from sample loading to the result analysis with visual and simple terms to avoid any human errors.

At MEDICA 2024, Sentinel is also highlighting FOBGold line, its complete line for fecal occult blood testing (FIT). This includes the SENTiFIT 270 high-speed FIT system with a throughput of up to 270 tests per hour and featuring a patented pierceable tube for high-volume CRC screening. Also being showcased is the SENTiFOB automated FIT system with a throughput of up to tests per and compatible with pierceable tubes. In addition, Sentinel is highlighting the CALiaGold quantitative latex immunoassay for fecal calprotectin measurement as a marker of intestinal inflammation. The CALiaGold solution, together with the SENTiFIT 270 and SENTiFOB automated analyzers, offers a specific diagnostic system to differentiate IBD (Inflammatory Bowel Disease) from IBS (Irritable Bowel Syndrome). Visitors to the Sentinel booth can also learn more about the FOB Gold system which comprises a unique “2 in 1” tube for sample collection and a new generation immunological latex reagent for the determination of FOB.

Related Links:
Sentinel Diagnostics 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Influenza Virus Test
NovaLisa Influenza Virus B IgM ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.